- Home
- Chemistry
- Drug Discovery and Development
- Therapeutic RNA Nanotechnology
Therapeutic RNA Nanotechnology
Immunomodulation and Dynamicity
edited by Kirill Afonin and Morgan Chandler
“This book comprehensively describes the pathway to progress in the field of nucleic acid nanotechnology, beginning with in silico design strategies and ending with a number of therapeutic and nanotechnological applications. The methods, big picture, and current progress presented in this book are an enormous asset to anyone endeavoring into this field.”
Prof. Yaroslava Yingling, North Carolina State University, USA
- Format: Hardcover
- ISBN: 9789814877183
- Subject: Drug Discovery and Development
- Published: July 2021
- Pages: 1228
USD $399.95
For Course Instructors: Inspection Copies
Retailers:
This collection of research articles and reviews covers the latest work in the design, delivery, dynamic abilities, immunorecognition, and therapeutic options of RNA nanoparticles. RNA nanotechnology is an emerging platform for therapeutics, with increasing clinical relevance as this technology becomes more widely used and approved for the treatment of various diseases.
Chapter 1
Generating New Specific RNA Interaction Interfaces Using C-Loops
Kirill A. Afonin and Neocles B. Leontis
Pages: 1-20
USD $34.95
Add to cartChapter 2
Specific RNA Self-Assembly with Minimal Paranemic Motifs
Kirill A. Afonin, Dennis J. Cieply, and Neocles B. Leontis
Pages: 21-44
USD $34.95
Add to cartChapter 3
In vitro assembly of cubic RNA-Based scaffolds designed in silico
Kirill A. Afonin, Eckart Bindewald, Alan J. Yaghoubian,Neil Voss, Erica Jacovetty, Bruce A. Shapiro, and Luc Jaeger
Pages: 45-66
USD $34.95
Add to cartChapter 4
Self-Assembling RNA Nanorings Based on RNAI/II Inverse Kissing Complexes
Wade W. Grabow, Paul Zakrevsky, Kirill A. Afonin, Arkadiusz Chworos, Bruce A. Shapiro, and Luc Jaeger
Pages: 67-94
USD $34.95
Add to cartChapter 5
Multistrand RNA Secondary Structure Prediction and Nanostructure Design Including Pseudoknots
Eckart Bindewald, Kirill Afonin, Luc Jaeger, and Bruce A. Shapiro
Pages: 95-120
USD $34.95
Add to cartChapter 6
Computational and experimental characterization of RNA cubic nanoscaffolds
Kirill A. Afonin, Wojciech Kasprzak, Eckart Bindewald, Praneet S. Puppala, Alex R. Diehl, Kenneth T. Hall, Tae Jin Kim, Michael T. Zimmermann, Robert L. Jernigan, Luc Jaeger, and Bruce A. Shapiro
Pages: 121-150
USD $34.95
Add to cartChapter 7
In silico Design and Enzymatic Synthesis of Functional RNA Nanoparticles
Kirill A. Afonin, Wojciech K. Kasprzak, Eckart Bindewald, Maria Kireeva, Matthias Viard, Mikhail Kashlev, and Bruce A. Shapiro
Pages: 151-176
USD $34.95
Add to cartChapter 8
Ring Catalog: A Resource for Designing Self- Assembling RNA Nanostructures
Lorena Parlea, Eckart Bindewald, Rishabh Sharan, Nathan Bartlett, Daniel Moriarty, Jerome Oliver, Kirill A. Afonin, and Bruce A. Shapiro
Pages: 177-200
USD $34.95
Add to cartChapter 9
Programmable RNA microstructures for coordinated delivery of siRNAs
Jaimie Marie Stewart, Mathias Viard, Hari K. K. Subramanian, Brandon K. Roark, Kirill A. Afonin, and Elisa Franco
Pages: 201-222
USD $34.95
Add to cartChapter 10
Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology
My N. Bui, M. Brittany Johnson, Mathias Viard, Emily Satterwhite, Angelica N. Martins, Zhihai Li, Ian Marriott, Kirill A. Afonin, and Emil F. Khisamutdinov
Pages: 223-248
USD $34.95
Add to cartChapter 11
Design and self-Assembly of siRNA-Functionalized RNA nanoparticles for use in automated nanomedicine
Kirill A. Afonin, Wade W. Grabow, Faye M. Walker, Eckart Bindewald, Marina A. Dobrovolskaia, Bruce A. Shapiro, and Luc Jaeger
Pages: 249-284
USD $34.95
Add to cartChapter 12
Co-transcriptional Assembly of Chemically Modified RNA Nanoparticles Functionalized with siRNAs
Kirill A. Afonin, Maria Kireeva, Wade W. Grabow, Mikhail Kashlev, Luc Jaeger, and Bruce A. Shapiro
Pages: 285-294
USD $34.95
Add to cartChapter 13
Multifunctional RNA Nanoparticles
Kirill A. Afonin, Matthias Viard, Alexey Y. Koyfman, Angelica N. Martins, Wojciech K. Kasprzak, Martin Panigai, Ravi Desai, Arti Santhanam, Wade W. Grabow, Luc Jaeger, Eliahu Heldman, Jakob Reiser, Wah Chiu, Eric O. Freed, and Bruce A. Shapiro
Pages: 295-324
USD $34.95
Add to cartChapter 14
Oxime Ether Lipids Containing Hydroxylated Head Groups are More Superior siRNA Delivery Agents Than Their Nonhydroxylated Counterparts
Kshitij Gupta, Stephanie J. Mattingly, Ralph J. Knipp, Kirill A. Afonin, Mathias Viard, Joseph T. Bergman, Marissa Stepler, Michael H. Nantz, Anu Puri, and Bruce A. Shapiro
Pages: 325-354
USD $34.95
Add to cartChapter 15
Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications
Kshitij Gupta, Kirill A. Afonin, Mathias Viard, Virginia Herrero, Wojciech Kasprzak, Ioannis Kagiampakis, Taejin Kim, Alexey Y. Koyfman, Anu Puri, Marissa Stepler, Alison Sappe, Vineet N. KewalRamani, Sarina Grinberg, Charles Linder, Eliahu Heldman, Robert Blumenthal, and Bruce A. Shapiro
Pages: 355-386
USD $34.95
Add to cartChapter 16
Magnetic nanoparticles loaded with functional RNA nanoparticles
Melissa Cruz-Acuña, Justin R. Halman, Kirill A. Afonin, Jon Dobson, and Carlos Rinaldi
Pages: 387-412
USD $34.95
Add to cartChapter 17
Multimodal Polysilsesquioxane Nanoparticles for Combinatorial Therapy and Gene Delivery in Triple-Negative Breast Cancer
Ridhima Juneja, Zachary Lyles, Hemapriyadarshini Vadarevu, Kirill A. Afonin, and Juan L. Vivero-Escoto
Pages: 413-450
USD $34.95
Add to cartChapter 18
A Cationic Amphiphilic Co-polymer as a Carrier of Nucleic Acid Nanoparticles (NANPs) for Controlled Gene Silencing, Immunostimulation, and Biodistribution
Justin R. Halman, Ki-Taek Kim, So-Jung Gwak, Richard Pace, M. Brittany Johnson, Morgan R. Chandler, Lauren Rackley, Mathias Viard, Ian Marriott, Jeoung Soo Lee, and Kirill A. Afonin
Pages: 451-476
USD $34.95
Add to cartChapter 19
Cellular Delivery of RNA Nanoparticles
Lorena Parlea, Anu Puri, Wojciech Kasprzak, Eckart Bindewald, Paul Zakrevsky, Emily Satterwhite, Kenya Joseph, Kirill A. Afonin, and Bruce A. Shapiro
Pages: 477-538
USD $34.95
Add to cartChapter 20
Exosome Mediated Delivery of Functional Nucleic Acid Nanoparticles (Nanps)
Senny Nordmeier, Weina Ke, Kirill A. Afonin, and Victoria Portnoy
Pages: 539-564
USD $34.95
Add to cartChapter 21
Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance in vitro
Ridhima Juneja, Hemapriyadarshini Vadarevu, Justin Halman, Mubin Tarannum, Lauren Rackley, Jacob Dobbs, Jose Marquez, Morgan Chandler, Kirill A. Afonin, and Juan L. Vivero-Escoto
Pages: 565-604
USD $34.95
Add to cartChapter 22
Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology
Kirill A. Afonin, Marina A. Dobrovolskaia, George Church, and Mark Bathe
Pages: 605-626
USD $34.95
Add to cartChapter 23
Activation of Different Split Functionalities on Re-association of Rna–Dna Hybrids
Kirill A. Afonin, Mathias Viard, Angelica N. Martins, Stephen J. Lockett, Anna E. Maciag, Eric O. Freed, Eliahu Heldman, Luc Jaeger, Robert Blumenthal, and Bruce A. Shapiro
Pages: 627-650
USD $34.95
Add to cartChapter 24
Co-transcriptional Production of Rna–Dna Hybrids for Simultaneous Release of Multiple Split Functionalities
Kirill A. Afonin, Ravi Desai, Mathias Viard, Maria L. Kireeva, Eckart Bindewald, Christopher L. Case, Anna E. Maciag, Wojciech K. Kasprzak, Taejin Kim, Alison Sappe, Marissa Stepler, Vineet N. KewalRamani, Mikhail Kashlev, Robert Blumenthal, and Bruce A. Shapiro
Pages: 651-680
USD $34.95
Add to cartChapter 25
Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles
Kirill A. Afonin, Mathias Viard, Ioannis Kagiampakis, Christopher L. Case, Marina A. Dobrovolskaia, Jen Hofmann, Ashlee Vrzak, Maria Kireeva, Wojciech K. Kasprzak, Vineet N. KewalRamani, and Bruce A. Shapiro
Pages: 681-706
USD $34.95
Add to cartChapter 26
Multistrand Structure Prediction of Nucleic Acid Assemblies and Design of RNA Switches
Eckart Bindewald, Kirill A. Afonin, Mathias Viard, Paul Zakrevsky, Taejin Kim, and Bruce A. Shapiro
Pages: 707-734
USD $34.95
Add to cartChapter 27
The Use of Minimal RNA Toeholds to Trigger the Activation of Multiple Functionalities
Kirill A. Afonin, Matthias Viard, Philip Tedbury, Eckart Bindewald, Lorena Parlea, Marshall Howington, Melissa Valdman, Alizah Johns-Boehme, Cara Brainerd, Eric O. Freed, and Bruce A. Shapiro
Pages: 735-754
USD $34.95
Add to cartChapter 28
Functionally-Interdependent Shape-Switching Nanoparticles with Controllable Properties
Justin R. Halman, Emily Satterwhite, Brandon Roark, Morgan Chandler, Mathias Viard, Anna Ivanina, Eckart Bindewald, Wojciech K. Kasprzak, Martin Panigaj, My N. Bui, Jacob S. Lu, Johann Miller, Emil F. Khisamutdinov, Bruce A. Shapiro, Marina A. Dobrovolskaia, and Kirill A. Afonin
Pages: 755-778
USD $34.95
Add to cartChapter 29
Dynamic Behavior of RNA Nanoparticles Analyzed by AFM on a Mica/Air Interface
Sameer Sajja, Morgan Chandler, Dmitry Fedorov, Wojciech K. Kasprzak, Alexander Lushnikov, Mathias Viard, Ankit Shah, Dylan Dang, Jared Dahl, Beamlak Worku, Marina A. Dobrovolskaia, Alexey Krasnoslobodtsev, Bruce A. Shapiro, and Kirill A. Afonin
Pages: 779-804
USD $34.95
Add to cartChapter 30
Broccoli Fluorets: Split Aptamers as a User-Friendly Fluorescent Toolkit for Dynamic RNA Nanotechnology
Morgan Chandler, Tatiana Lyalina, Justin Halman, Lauren Rackley, Lauren Lee, Dylan Dang, Weina Ke, Sameer Sajja, Steven Woods, Shrija Acharya, Elijah Baumgarten, Jonathan Christopher, Emman Elshalia, Gabriel Hrebien, Kinzey Kublank, Saja Saleh, Bailey Stallings, Michael Tafere, C Striplin, K Afonin
Pages: 805-824
USD $34.95
Add to cartChapter 31
Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology
Martin Panigaj, M. Brittany Johnson, Weina Ke, Jessica McMillan, Ekaterina A. Goncharova, Morgan Chandler, and Kirill A. Afonin
Pages: 825-884
USD $34.95
Add to cartChapter 32
Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling
Morgan Brittany Johnson, Justin R. Halman, Emily Satterwhite, Alexey V. Zakharov, My N. Bui, Kheiria Benkato, Victoria Goldsworthy, Taejin Kim, Enping Hong, Marina A. Dobrovolskaia, Emil F. Khisamutdinov, Ian Marriott, and Kirill A. Afonin
Pages: 885-910
USD $34.95
Add to cartChapter 33
Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles
Enping Hong, Justing R. Halman, Ankit B. Shah, Emil F. Khisamutdinov, Marina A. Dobrovolskaia, and Kirill A. Afonin
Pages: 911-942
USD $34.95
Add to cartChapter 34
RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition
Lauren Rackley, Jaimie Marie Stewart, Jacqueline Salotti, Andrey Krokhotin, Ankit Shah, Justin R. Halman, Ridhima Juneja, Jaclyn Smollett, Lauren Lee, Kyle Roark, Mathias Viard, Mubin Tarannum, Juan Vivero-Escoto, Peter F. Johnson, Marina A. Dobrovolskaia, Nikolay Dokholyan, Elisa Franco, K Afonin
Pages: 943-970
USD $34.95
Add to cartChapter 35
RNA–DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-kB in Human Cells
Weina Ke, Enping Hong, Renata F. Saito, Maria Cristina Rangel, Jian Wang, Mathias Viard, Melina Richardson, Emil F. Khisamutdinov, Martin Panigaj, Nikolay V. Dokholyan, Roger Chammas, Marina A. Dobrovolskaia, and Kirill A. Afonin
Pages: 971-1000
USD $34.95
Add to cartChapter 36
Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells
Enping Hong, Justin R. Halman, Ankit Shah, Edward Cedrone, Nguyen Truong, Kirill A. Afonin, and Marina A. Dobrovolskaia
Pages: 1001-1022
USD $34.95
Add to cartChapter 37
Smart-Responsive Nucleic Acid Nanoparticles (NANPs) with the Potential to Modulate Immune Behavior
Morgan Chandler and Kirill A. Afonin
Pages: 1023-1044
USD $34.95
Add to cartChapter 38
Innate Immune Responses Triggered by Nucleic Acids Inspire the Design of Immunomodulatory Nucleic Acid Nanoparticles (NANPs)
Morgan Chandler, Morgan Brittany Johnson, Martin Panigaj, and Kirill A. Afonin
Pages: 1045-1060
USD $34.95
Add to cartChapter 39
Retinoic Acid Inducible Gene-I Mediated Detection of Bacterial Nucleic Acids in Human Microglial Cells
M. Brittany Johnson, Justin R. Halman, Amanda R. Burmeister, Saralynn Currin, Emil F. Khisamutdinov, Kirill A. Afonin, and Ian Marriott
Pages: 1061-1090
USD $34.95
Add to cartChapter 40
Use of Human Peripheral Blood Mononuclear Cells to Define Immunological Properties of Nucleic Acid Nanoparticles
Marina A. Dobrovolskaia and Kirill A. Afonin
Pages: 1091-1136
USD $34.95
Add to cartChapter 41
The Immunorecognition, Subcellular Compartmentalization, and Physicochemical Properties of Nucleic Acid Nanoparticles can be Controlled by Composition Modification
Morgan Brittany Johnson, Justin R. Halman, Daniel K. Miller, Joseph S. Cooper, Emil F. Khisamutdinov, Ian Marriott, and Kirill A. Afonin
Pages: 1137-1170
USD $34.95
Add to cartKirill A. Afonin is an associate professor in the Department of Chemistry, University of North Carolina at Charlotte, vice president and founding council member of the International Society of RNA Nanotechnology and Nanomedicine (ISRNN). He has focused his studies on RNA biology and nanotechnology with potential diagnostic and therapeutic applications in biomedicine. He has published more than 65 articles in international peer-reviewed journals, co-authored 16 book chapters, edited two books, and holds 12 US patents, two of which are licensed to biotech companies. He is also a member of several scientific societies and a reviewer for many international scientific journals and funding agencies. Dr. Afonin is a recipient of two NIH Fellows Awards for Research Excellence, a prestigious NIH Maximizing Investigators’ Research Award, and two NIH R01s.
Morgan Chandler received her BS in biological sciences with honors from the University of North Carolina at Charlotte prior to joining the Nanoscale Science PhD Program there. Her work in the Afonin’s lab has focused on the dynamic design, delivery, and immunostimulatory properties of nucleic acid nanoparticles and their interactions with other classes of biomolecules. Morgan has co-authored more than a dozen papers and four book chapters in the field.
“This book comprehensively describes the pathway to progress in the field of nucleic acid nanotechnology, beginning with in silico design strategies and ending with a number of therapeutic and nanotechnological applications. The methods, big picture, and current progress presented in this book are an enormous asset to anyone endeavoring into this field.”
~Prof. Yaroslava Yingling, North Carolina State University, USA
“Previously unknown immunostimulatory properties of nucleic acid nanomaterials have presented a translational challenge which slowed down therapeutic development of these novel materials. The timely topics covered in this book reflect the journey through these preliminary investigations and hopefully will serve as the foundation for future work in this emerging area of nanomedicine.”
~Dr. Marina Dobrovolskaia, National Cancer Institute, USA
“The programmed and rational design of nucleic acid nanoparticles have a lot to offer to the fields of modern nanomedicine and nanotechnology. Dynamic approaches to therapeutics have great potential for customizability and increased specificity, interacting with particular inputs based on nature’s data processing molecule. It is exciting to see all of the potential of this technology gathered into one book.”
~Prof. Emil Khisamutdinov, Ball State University, USA
“The book provides a very nice walkthrough for the various recent technologies, both computational and experimental, that have been developed in the past few years and are now available for end users in therapeutic nucleic acid nanotechnology.”
~Prof. Nikolay Dokholyan, Pennsylvania State University, USA